News & Insights


An Analysis of the Prescription Drug Pricing Provisions of the Inflation Reduction Act of 2022

By the time of this webinar, Congress will have passed and the President will have signed the most consequential drug pricing and benefit reform act since the ACA in 2010. Please join our experienced panel as they unpack the bill, explain its mechanics, and provide insight into its ramifications for drug and biologics manufacturers. The panel will consider the compliance and government program liability implications of the new law, focusing on:

  • Medicare price negotiation for “high-priced” single source drugs
  • Special treatment for biologics and biosimilars
  • New Medicare drug inflation rebates
  • Part D benefit redesign 

For questions, contact Chayako Williams at


King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias at King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.

Event Details

Date: August 18, 2022

Time: 12:00 pm (ET)

Attend This Webinar

Please register soon. You do not have to be a client to attend, and there is no charge.